Hong Kong Pharma (NASDAQ:HKPD) shares opened at $3.50 after being priced at $4 per share, later hitting a high of $3.79 and a low of $3. The stock recent sold for $3.19 at around 3:30 p.m. ET.

Hong Kong has also established itself as the premier stock market for Chinese firms seeking to list abroad. In 2015, mainland Chinese companies constituted about 50% of the firms listed on the ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

especially after the positive impulse from dividend payouts by HK-listed firms and (as) IPO activity fades," they said in a note published this week. "The onshore buying of Hong Kong stocks may ...

Hong Kong stocks retreated ... downgraded its rating on the stock. Bank of China lost more than 3 per cent as the stock traded without an entitlement to a dividend payout. Alibaba Group Holding ...

HSBC’s optimism for Hong Kong-listed Chinese stocks contrasts with the bearish outlooks of competitors like Goldman Sachs and Morgan Stanley. Goldman Sachs downgraded Hong Kong to underweight in ...

Hong Kong stocks surrendered gains, sending the benchmark index back to a six-week low, on concern sticky deflation in mainland China will hamper efforts to recharge the economy. Tencent Holdings ...

Here we highlight a subset of our preferred stocks from the screener ... to estimated fair value, its dividend yield of 4.82% is below top-tier levels in Hong Kong. Recent executive changes ...